Shearman & Sterling Advises on $1.8 Billion Financing for Watson Pharmaceuticals’ Acquisition

Shearman & Sterling advised Bank of America, N.A. as administrative agent, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC as joint book managers and joint lead arrangers and Barclays Bank PLC and J.P. Morgan Securities LLC as joint lead arrangers in connection with a $1.8 billion term loan financing for Watson Pharmaceuticals, Inc. related to its acquisition of Actavis Pharma Holding 4 ehf. and Actavis Inc.

More >>

Tags:  Shearman & Sterling LLP | New York

Jackson Walker Represents QSpex Technologies in $20.5 Million Equity Investment

Jackson Walker L.L.P. recently assisted client QSpex Technologies, Inc. in securing approximately $20.5 million in Series D funding, which will enable the company to expand its production capacity and increase its sales and marketing staff to support a major U.S. product launch. Based in Alpharetta, Georgia, QSpex uses proprietary technology to develop systems that enable vision care providers to efficiently produce a wide range of top-quality spectacle lenses with a variety of premium features.

More >>

Tags:  Jackson Walker, LLP | Houston